Status:
NOT_YET_RECRUITING
Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.
Lead Sponsor:
Assiut University
Conditions:
Warts
Eligibility:
All Genders
18-60 years
Brief Summary
To assess the clinical efficacy and safety of topical imiquimod 5% cream combined with cryotherapy versus either of theme alone for the treatment of common warts by clinical and dermoscopic assessment...
Detailed Description
Topical Imiquimod 5% cream Combined with Cryotherapy Versus either of them alone in Treatment of Common Warts: A prospective Randomized Comparative Trial
Eligibility Criteria
Inclusion
- Patients with common warts diagnosed clinically and by dermoscopy.
- Patients older than 18years old.
Exclusion
- Pregnancy and lactation.
- Immunosuppression or being under any kind of treatment causing
- absolute or relative immunosuppression.
- Patients with chronic systemic diseases.
- All cases of bleeding tendency or using anticoagulants.
- Concurrent use of systemic or topical treatments of warts in the last 4 weeks.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06973473
Start Date
July 1 2025
End Date
August 1 2026
Last Update
May 15 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.